ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 168,73
0,00%
DAX
18 164,06
-0,86%
Brent Oil
86,45
-0,09%
Bitcoin
61 979,15
-1,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Compass Therapeutics Inc (CMPX)

  7. Compass Therapeutics Inc (CMPX) Actualités

CMPX

Compass Therapeutics (CMPX)

Compass Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CMPX
DateHeureSourceTitreSymboleSociété
17/06/202414h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
30/05/202414h00GlobeNewswire Inc.Compass Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CMPXCompass Therapeutics Inc
28/05/202422h10GlobeNewswire Inc.Compass Therapeutics Announces CEO TransitionNASDAQ:CMPXCompass Therapeutics Inc
23/05/202423h05GlobeNewswire Inc.Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual MeetNASDAQ:CMPXCompass Therapeutics Inc
14/05/202414h00GlobeNewswire Inc.Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:CMPXCompass Therapeutics Inc
13/05/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
13/05/202414h00GlobeNewswire Inc.Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
25/04/202414h00GlobeNewswire Inc.Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously TreatedNASDAQ:CMPXCompass Therapeutics Inc
16/04/202414h00GlobeNewswire Inc.Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid TumorsNASDAQ:CMPXCompass Therapeutics Inc
12/04/202414h00GlobeNewswire Inc.Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual ConferenceNASDAQ:CMPXCompass Therapeutics Inc
10/04/202414h00GlobeNewswire Inc.Compass Therapeutics to Participate in the Stifel Targeted Oncology DaysNASDAQ:CMPXCompass Therapeutics Inc
09/04/202418h00GlobeNewswire Inc.Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPXCompass Therapeutics Inc
21/03/202414h00GlobeNewswire Inc.Compass Therapeutics Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
11/03/202415h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
29/02/202414h00GlobeNewswire Inc.Compass Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:CMPXCompass Therapeutics Inc
28/02/202414h00GlobeNewswire Inc.Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical TrialNASDAQ:CMPXCompass Therapeutics Inc
05/01/202414h00GlobeNewswire Inc.Compass Therapeutics Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
09/11/202313h30GlobeNewswire Inc.Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
07/11/202314h00GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
03/08/202314h00GlobeNewswire Inc.Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
22/06/202322h05GlobeNewswire Inc.Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® IndexesNASDAQ:CMPXCompass Therapeutics Inc
04/05/202314h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPXCompass Therapeutics Inc
04/05/202314h30GlobeNewswire Inc.Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
27/04/202322h26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CMPXCompass Therapeutics Inc
26/04/202314h30GlobeNewswire Inc.Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQNASDAQ:CMPXCompass Therapeutics Inc
19/04/202314h30GlobeNewswire Inc.Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology DaysNASDAQ:CMPXCompass Therapeutics Inc
28/03/202314h30GlobeNewswire Inc.Compass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology SymposiumNASDAQ:CMPXCompass Therapeutics Inc
15/03/202313h30GlobeNewswire Inc.Compass Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CMPXCompass Therapeutics Inc
14/02/202320h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMPXCompass Therapeutics Inc
10/02/202322h02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CMPXCompass Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CMPX

Dernières Valeurs Consultées

EU
PX4
SBF 120
EU
PX1
CAC 40
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
EU
SGO
Cie de SaintGobain
USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
CAP
Capgemini
NYSE
JPM
JP Morgan Chase
EU
HO
Thales
EU
EN
Bouygues
EU
AI
Air Liquide
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés